Loading...
Efficacy of JAK inhibitors in Crohn’s Disease
Inhibition of Janus kinases [JAKs] in Crohn’s disease [CD] patients has shown conflicting results in clinical trials. Tofacitinib, a pan-JAK inhibitor, showed efficacy in ulcerative colitis [UC] and has been approved for the treatment of patients with moderate to severe UC. In contrast, studies in C...
Na minha lista:
| Udgivet i: | J Crohns Colitis |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7395306/ https://ncbi.nlm.nih.gov/pubmed/31781755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjz186 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|